COVID-19 Impact on Cerebral and Tissue Oximetry Devices Market, Global Research Reports 2020-2021
Table of Contents1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Cerebral and Tissue Oximetry Devices Industry
1.7 COVID-19 Impact: Cerebral and Tissue Oximetry Devices Market Trends
2 Global Cerebral and Tissue Oximetry Devices Quarterly Market Size Analysis
2.1 Cerebral and Tissue Oximetry Devices Business Impact Assessment - COVID-19
2.1.1 Global Cerebral and Tissue Oximetry Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.1.2 Global Cerebral and Tissue Oximetry Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Cerebral and Tissue Oximetry Devices Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 Global Cerebral and Tissue Oximetry Devices Quarterly Market Size by Manufacturers, 2019 VS 2020
3.2 Global Cerebral and Tissue Oximetry Devices Factory Price by Manufacturers
3.3 Location of Key Manufacturers Cerebral and Tissue Oximetry Devices Manufacturing Factories and Area Served
3.4 Date of Key Manufacturers Enter into Cerebral and Tissue Oximetry Devices Market
3.5 Key Manufacturers Cerebral and Tissue Oximetry Devices Product Offered
3.6 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Cerebral and Tissue Oximetry Devices Segments, By Type
4.1 Introduction
1.4.1 Portable
1.4.2 Desktop
4.2 By Type, Global Cerebral and Tissue Oximetry Devices Market Size, 2019-2021
4.2.1 By Type, Global Cerebral and Tissue Oximetry Devices Market Size by Type, 2020-2021
4.2.2 By Type, Global Cerebral and Tissue Oximetry Devices Price, 2020-2021
5 Impact of Covid-19 on Cerebral and Tissue Oximetry Devices Segments, By Application
5.1 Overview
5.5.1 Clinicals
5.5.2 Hospitials
5.5.3 Others
5.2 By Application, Global Cerebral and Tissue Oximetry Devices Market Size, 2019-2021
5.2.1 By Application, Global Cerebral and Tissue Oximetry Devices Market Size by Application, 2019-2021
5.2.2 By Application, Global Cerebral and Tissue Oximetry Devices Price, 2020-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 CAS Medical Systems
7.1.1 CAS Medical Systems Business Overview
7.1.2 CAS Medical Systems Cerebral and Tissue Oximetry Devices Quarterly Production and Revenue, 2020
7.1.3 CAS Medical Systems Cerebral and Tissue Oximetry Devices Product Introduction
7.1.4 CAS Medical Systems Response to COVID-19 and Related Developments
7.2 Masimo
7.2.1 Masimo Business Overview
7.2.2 Masimo Cerebral and Tissue Oximetry Devices Quarterly Production and Revenue, 2020
7.2.3 Masimo Cerebral and Tissue Oximetry Devices Product Introduction
7.2.4 Masimo Response to COVID-19 and Related Developments
7.3 Medtronic
7.3.1 Medtronic Business Overview
7.3.2 Medtronic Cerebral and Tissue Oximetry Devices Quarterly Production and Revenue, 2020
7.3.3 Medtronic Cerebral and Tissue Oximetry Devices Product Introduction
7.3.4 Medtronic Response to COVID-19 and Related Developments
7.4 Nonin Medical
7.4.1 Nonin Medical Business Overview
7.4.2 Nonin Medical Cerebral and Tissue Oximetry Devices Quarterly Production and Revenue, 2020
7.4.3 Nonin Medical Cerebral and Tissue Oximetry Devices Product Introduction
7.4.4 Nonin Medical Response to COVID-19 and Related Developments
7.5 Hamamatsu Photonics
7.5.1 Hamamatsu Photonics Business Overview
7.5.2 Hamamatsu Photonics Cerebral and Tissue Oximetry Devices Quarterly Production and Revenue, 2020
7.5.3 Hamamatsu Photonics Cerebral and Tissue Oximetry Devices Product Introduction
7.5.4 Hamamatsu Photonics Response to COVID-19 and Related Developments
7.6 Hutchinson Technology
7.6.1 Hutchinson Technology Business Overview
7.6.2 Hutchinson Technology Cerebral and Tissue Oximetry Devices Quarterly Production and Revenue, 2020
7.6.3 Hutchinson Technology Cerebral and Tissue Oximetry Devices Product Introduction
7.6.4 Hutchinson Technology Response to COVID-19 and Related Developments
7.7 HyperMed
7.7.1 HyperMed Business Overview
7.7.2 HyperMed Cerebral and Tissue Oximetry Devices Quarterly Production and Revenue, 2020
7.7.3 HyperMed Cerebral and Tissue Oximetry Devices Product Introduction
7.7.4 HyperMed Response to COVID-19 and Related Developments
7.8 ISS
7.8.1 ISS Business Overview
7.8.2 ISS Cerebral and Tissue Oximetry Devices Quarterly Production and Revenue, 2020
7.8.3 ISS Cerebral and Tissue Oximetry Devices Product Introduction
7.8.4 ISS Response to COVID-19 and Related Developments
7.9 Moor Instruments
7.9.1 Moor Instruments Business Overview
7.9.2 Moor Instruments Cerebral and Tissue Oximetry Devices Quarterly Production and Revenue, 2020
7.9.3 Moor Instruments Cerebral and Tissue Oximetry Devices Product Introduction
7.9.4 Moor Instruments Response to COVID-19 and Related Developments
7.10 Ornim Medical
7.10.1 Ornim Medical Business Overview
7.10.2 Ornim Medical Cerebral and Tissue Oximetry Devices Quarterly Production and Revenue, 2020
7.10.3 Ornim Medical Cerebral and Tissue Oximetry Devices Product Introduction
7.10.4 Ornim Medical Response to COVID-19 and Related Developments
7.11 Reflectance Medical
7.11.1 Reflectance Medical Business Overview
7.11.2 Reflectance Medical Cerebral and Tissue Oximetry Devices Quarterly Production and Revenue, 2020
7.11.3 Reflectance Medical Cerebral and Tissue Oximetry Devices Product Introduction
7.11.4 Reflectance Medical Response to COVID-19 and Related Developments
7.12 Spectros
7.12.1 Spectros Business Overview
7.12.2 Spectros Cerebral and Tissue Oximetry Devices Quarterly Production and Revenue, 2020
7.12.3 Spectros Cerebral and Tissue Oximetry Devices Product Introduction
7.12.4 Spectros Response to COVID-19 and Related Developments
7.13 ViOptix
7.13.1 ViOptix Business Overview
7.13.2 ViOptix Cerebral and Tissue Oximetry Devices Quarterly Production and Revenue, 2020
7.13.3 ViOptix Cerebral and Tissue Oximetry Devices Product Introduction
7.13.4 ViOptix Response to COVID-19 and Related Developments
8 Supply Chain and Sales Channels Analysis
8.1 Cerebral and Tissue Oximetry Devices Supply Chain Analysis
8.1.1 Cerebral and Tissue Oximetry Devices Supply Chain Analysis
8.1.2 Covid-19 Impact on Cerebral and Tissue Oximetry Devices Supply Chain
8.2 Distribution Channels Analysis
8.2.1 Cerebral and Tissue Oximetry Devices Distribution Channels
8.2.2 Covid-19 Impact on Cerebral and Tissue Oximetry Devices Distribution Channels
8.2.3 Cerebral and Tissue Oximetry Devices Distributors
8.3 Cerebral and Tissue Oximetry Devices Customers
9 Key Findings
10 Appendix
10.1 About Us
10.2 Disclaimer
List of TablesTable 1. Overview of the World Economic Outlook Projections
Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)
Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)
Table 7. Covid-19 Impact: Global Major Government Policy
Table 8. The Covid-19 Impact on Cerebral and Tissue Oximetry Devices Assessment
Table 9. COVID-19 Impact: Cerebral and Tissue Oximetry Devices Market Trends
Table 10. COVID-19 Impact Global Cerebral and Tissue Oximetry Devices Market Size
Table 11. Global Cerebral and Tissue Oximetry Devices Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)
Table 12. Global Cerebral and Tissue Oximetry Devices Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)
Table 13. Global Cerebral and Tissue Oximetry Devices Quarterly Market Size, 2020 (US$ Million) & (K Units)
Table 14. Global Cerebral and Tissue Oximetry Devices Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)
Table 15. Global Cerebral and Tissue Oximetry Devices Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)
Table 16. Global Cerebral and Tissue Oximetry Devices Market Growth Drivers
Table 17. Global Cerebral and Tissue Oximetry Devices Market Restraints
Table 18. Global Cerebral and Tissue Oximetry Devices Market Opportunities
Table 19. Global Cerebral and Tissue Oximetry Devices Market Challenges
Table 20. Key Manufacturers Cerebral and Tissue Oximetry Devices Quarterly Revenue, 2019 VS 2020 (US$ Million)
Table 21. Top Manufacturers, Cerebral and Tissue Oximetry Devices Market Size, 2019 (K Units) & (US$ Million)
Table 22. Cerebral and Tissue Oximetry Devices Factory Price by Manufacturers 2020 (USD/Unit)
Table 23. Location of Key Manufacturers Cerebral and Tissue Oximetry Devices Manufacturing Plants
Table 24. Key Manufacturers Cerebral and Tissue Oximetry Devices Market Served
Table 25. Date of Key Manufacturers Enter into Cerebral and Tissue Oximetry Devices Market
Table 26. Key Manufacturers Cerebral and Tissue Oximetry Devices Product Type
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cerebral and Tissue Oximetry Devices Market Size by Type, 2020, (US$ Million)
Table 29. Global Cerebral and Tissue Oximetry Devices Market Size by Type, 2020 (K Units)
Table 30. Global Cerebral and Tissue Oximetry Devices Price: by Type, 2020-2021 (USD/Unit)
Table 31. Global Cerebral and Tissue Oximetry Devices Market Size by Application: 2020-2021 (US$ Million)
Table 32. Global Cerebral and Tissue Oximetry Devices Market Size by Application, 2020-2021 (K Units)
Table 33. Global Cerebral and Tissue Oximetry Devices Price: by Application, 2020-2021 (USD/Unit)
Table 34. Global Cerebral and Tissue Oximetry Devices Market Size by Region, 2019-2021 (US$ Million)
Table 35. Global Cerebral and Tissue Oximetry Devices Market Size by Region, 2019-2021 (K Units)
Table 36. By Country, North America Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million)
Table 37. By Country, North America Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (K Units)
Table 38. US Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 39. Canada Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)
Table 41. By Country, Europe Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million)
Table 42. By Country, Europe Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (K Units)
Table 43. Germany Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 44. France Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 45. UK Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 46. Italy Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)
Table 48. By Region, Asia-Pacific Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million)
Table 49. By Region, Asia-Pacific Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (K Units)
Table 50. China Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 51. Japan Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 52. South Korea Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 53. India Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 54. ASEAN Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 55. Latin America Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 56. Middle East and Africa Cerebral and Tissue Oximetry Devices Market Size, 2019-2021 (US$ Million) & (K Units)
Table 57. CAS Medical Systems Business Overview
Table 58. CAS Medical Systems Cerebral and Tissue Oximetry Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 59. CAS Medical Systems Cerebral and Tissue Oximetry Devices Product
Table 60. CAS Medical Systems Response to COVID-19 and Related Developments
Table 61. Masimo Business Overview
Table 62. Masimo Cerebral and Tissue Oximetry Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 63. Masimo Cerebral and Tissue Oximetry Devices Product
Table 64. Masimo Response to COVID-19 and Related Developments
Table 65. Medtronic Business Overview
Table 66. Medtronic Cerebral and Tissue Oximetry Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 67. Medtronic Cerebral and Tissue Oximetry Devices Product
Table 68. Medtronic Response to COVID-19 and Related Developments
Table 69. Nonin Medical Business Overview
Table 70. Nonin Medical Cerebral and Tissue Oximetry Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 71. Nonin Medical Cerebral and Tissue Oximetry Devices Product
Table 72. Nonin Medical Response to COVID-19 and Related Developments
Table 73. Hamamatsu Photonics Business Overview
Table 74. Hamamatsu Photonics Cerebral and Tissue Oximetry Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 75. Hamamatsu Photonics Cerebral and Tissue Oximetry Devices Product
Table 76. Hamamatsu Photonics Response to COVID-19 and Related Developments
Table 77. Hutchinson Technology Business Overview
Table 78. Hutchinson Technology Cerebral and Tissue Oximetry Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 79. Hutchinson Technology Cerebral and Tissue Oximetry Devices Product
Table 80. Hutchinson Technology Response to COVID-19 and Related Developments
Table 81. HyperMed Business Overview
Table 82. HyperMed Cerebral and Tissue Oximetry Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 83. HyperMed Cerebral and Tissue Oximetry Devices Product
Table 84. HyperMed Response to COVID-19 and Related Developments
Table 85. ISS Business Overview
Table 86. ISS Cerebral and Tissue Oximetry Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 87. ISS Cerebral and Tissue Oximetry Devices Product
Table 88. ISS Response to COVID-19 and Related Developments
Table 89. Moor Instruments Business Overview
Table 90. Moor Instruments Cerebral and Tissue Oximetry Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 91. Moor Instruments Cerebral and Tissue Oximetry Devices Product
Table 92. Moor Instruments Response to COVID-19 and Related Developments
Table 93. Ornim Medical Business Overview
Table 94. Ornim Medical Cerebral and Tissue Oximetry Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 95. Ornim Medical Cerebral and Tissue Oximetry Devices Product
Table 96. Ornim Medical Response to COVID-19 and Related Developments
Table 97. Reflectance Medical Business Overview
Table 98. Reflectance Medical Cerebral and Tissue Oximetry Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 99. Reflectance Medical Cerebral and Tissue Oximetry Devices Product
Table 100. Reflectance Medical Response to COVID-19 and Related Developments
Table 101. Spectros Business Overview
Table 102. Spectros Cerebral and Tissue Oximetry Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 103. Spectros Cerebral and Tissue Oximetry Devices Product
Table 104. Spectros Response to COVID-19 and Related Developments
Table 105. ViOptix Business Overview
Table 106. ViOptix Cerebral and Tissue Oximetry Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020
Table 107. ViOptix Cerebral and Tissue Oximetry Devices Product
Table 108. ViOptix Response to COVID-19 and Related Developments
Table 109. Cerebral and Tissue Oximetry Devices Distributors List
Table 110. Cerebral and Tissue Oximetry Devices Customers List
Table 111. Covid-19 Impact on Cerebral and Tissue Oximetry Devices Customers
List of FiguresFigure 1. Cerebral and Tissue Oximetry Devices Product Picture
Figure 2. Cerebral and Tissue Oximetry Devices Market Segmentation
Figure 3. Research Objectives
Figure 4. Research Process
Figure 5. Data Triangulation
Figure 6. Research Approach
Figure 7. Commodity Prices-Metals Price Indices
Figure 8. Commodity Prices- Precious Metal Price Indices
Figure 9. Commodity Prices- Agricultural Raw Material Price Indices
Figure 10. Commodity Prices- Food and Beverage Price Indices
Figure 11. Commodity Prices- Fertilizer Price Indices
Figure 12. Commodity Prices- Energy Price Indices
Figure 13. G20+: Economic Policy Responses to COVID-19
Figure 14. Global Cerebral and Tissue Oximetry Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)
Figure 15. Global Cerebral and Tissue Oximetry Devices Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)
Figure 16. Global Cerebral and Tissue Oximetry Devices Market Size, Quarterly Growth, 2020-2021 (%)
Figure 17. Global Cerebral and Tissue Oximetry Devices Market Size, Market Share by Type, 2019 VS 2020 (%)
Figure 18. Global Cerebral and Tissue Oximetry Devices Market Size, Market Share by Application, 2019 VS 2020 (%)
Figure 19. Global Cerebral and Tissue Oximetry Devices Market Size Market Share by Region, 2019 VS 2020 (%)
Figure 20. United States Composite PMI and GDP
Figure 21. Eurozone Composite PMI and GDP
Figure 22. Eurozone Core v. Periphery PMI Output Indices
Figure 23. Core v. Periphery PMI Employment Indices
Figure 24. UK Composite PMI and GDP
Figure 25. Caixin China Composite Output Index
Figure 26. Caixin China General Services Business Activity Index
Figure 27. Japan Composite Output Index
Figure 28. South Korea Manufacturing PMI
Figure 29. India Composite Output Index
Figure 30. ASEAN Manufacturing PMI
Figure 31. By Region, Asia-Pacific Cerebral and Tissue Oximetry Devices Market Size Market Share, 2019-2021